Background: Sensitivity to erthanol's locomotor activating and reinforcing effects may be influenced by some common neural mechanisms. Mice selectively bred in replicate for increased (FAST-1 and FAST-2) and decreased (SLOW-1 and SLOW-2) sensitivity to ethanol's locomotor stimulant effects are useful for investigating the neural substrates of ethanol's effects. Previous studies have suggested that differences in N-methyl-D-aspartate (NMDA) receptors may underlie differences in ethanol-induced locomotion in these mice. This study examined the responses of FAST and SLOW mice to ketamine, a fast-acting NMDA antagonist. In addition, reverse-selected lines (r-FAST-1, r-FAST-2, r-SLOW-1, and r-SLOW-2) were tested as a means of verifying correlations detected in the forward-selected lines. Two initial studies characterized ketamine-induced locomotion in DBA/2J (D2) mice, an inbred strain chosen for its high sensitivity to ethanol-induced locomotion.
S
TUDIES USING ANIMAL models of drug selfadministration and sensitivity have revealed that the reinforcing and locomotor stimulant effects of several drugs have some brain substrates in common (Amalric and Koob, 1993; Tzschentke and Schmidt, 2000; Wise and Bozarth, 1985) . In some genetic animal models, evidence for an association between sensitivity to ethanol-induced activation and sensitivity to ethanol's reinforcing effects has been obtained (Church et al., 1979; Dudek and Phillips, 1983; Risinger et al., 1994 ; but see Sanchez et al., 1996) . In fact, some data suggest that the initial response to ethanol may predict an individual's tendency to later develop alcoholism (Heath et al., 2001; Holdstock et al., 2000; Schuckit and Smith, 2001) . These data suggest that there are genes that pleiotropically influence ethanol sensitivity and addiction. Thus, understanding the effects of ethanol on simple behaviors such as locomotion may provide a foundation for understanding more complex behaviors, such as addiction.
Ethanol has direct effects on several neuronal systems and interacts indirectly with many others. In vitro studies have shown that ethanol inhibits the N-methyl-D-aspartate (NMDA) receptor, a subclass of the glutamate receptors (Dildy-Mayfield and Leslie, 1991) . This property of ethanol may be an important mediator of its stimulant properties, because noncompetitive NMDA antagonists such as MK-801, phencyclidine, and ketamine have been shown to increase locomotion in rodents (Koek et al., 1989; Tricklebank et al., 1989) . However, ethanol has effects on other neurotransmitter receptors as well. For example, ethanol potentiates chloride influx through subtypes of the ␥-aminobutyric acid (GABA) receptor, a property that is likely to be partially responsible for its stimulant effects . This nonspecificity makes it difficult to ascertain whether ethanol's NMDA antagonist properties have relevancy to its stimulant properties.
By use of selective breeding techniques, mice with high (FAST) and low (SLOW) locomotor responses to ethanol were created (Crabbe et al., 1987; Phillips et al., 1991 Phillips et al., , 2002 Shen et al., 1995) . SLOW mice are not only resistant to ethanol stimulation, but also more sensitive to ethanol's locomotor depressant effects. Selected lines such as these are useful in identifying traits that may be genetically correlated with the selection trait. For example, hypothesizing that sensitivity to ethanol's locomotor effects may be influenced by the same genes that influence sensitivity to the locomotor effects of other NMDA antagonists, found that FAST mice exhibited more locomotor activity after an acute injection of MK-801 than did SLOW mice. Similar findings have been found with GABA A allosteric modulators, including pentobarbital, diazepam, and allopregnanolone (Palmer et al., 2002a,b; Phillips et al., 1992) . Further, Daniell and Phillips (1994) found that ethanol inhibited glutamate-induced calcium influx in microsacs prepared from the brains of SLOW mice, but not FAST mice. These data suggest that differences between the FAST and SLOW mice in response to ethanol and other drugs may be associated with specific selection-induced changes in receptor function.
One problem when considering correlations suggested from selected line studies is that spurious correlations can arise by chance fixation of genes unrelated to the selection phenotype. Two replicates of the FAST and SLOW lines (referred to as the FAST-1, FAST-2, SLOW-1, and SLOW-2 lines) were created to provide stronger evidence in correlational studies. A difference found between both replicates of selected lines is unlikely to have occurred by chance and therefore provides strong evidence that the trait under investigation is under the pleiotropic influence of genes relevant to ethanol-induced stimulation. In addition, replicate reverse-selected lines were created in our laboratory by selectively breeding the "slowest" FAST mice with each other and the "fastest" SLOW mice with each other. These reverse-selected lines, named r-FAST and r-SLOW, exhibited similar sensitivity to the locomotor stimulant effects of the selection dose of ethanol (2 g/kg) after 16 generations of reverse selection (Phillips et al., 2002) . These lines provide another method for verifying putative genetic correlations detected in the FAST and SLOW lines. A nonselected trait that is divergent in the forward-selected lines may be influenced by some of the same genes as those that influence the selection trait (i.e., ethanol-induced locomotion). However, it is possible that the trait became divergent as a result of random genetic drift and chance fixation of genes irrelevant to the selection trait. Examining the potentially genetically correlated trait in the reverse lines helps to distinguish between these two possibilities. If the trait is no longer divergent in the reverse-selected lines, the conclusion that the trait is genetically correlated with the selection trait is strengthened. If the reverse lines continue to remain divergent, the possibility is raised that the genes underlying the two traits are unrelated and that the divergence observed in the forward-selected lines occurred spuriously, perhaps through random genetic drift and chance fixation of selection trait-relevant genes. However, it is also possible that genes with pleiotropic influence on the selection and alternative traits were fixed during forward selection and that the lack of heterogeneity at these loci prevented reverse-selection from having any effect. Therefore, whereas these studies do not allow us to draw definitive conclusions when changes in an alternative trait are not seen in the reverse-selected lines, they do provide confirmatory evidence of genetic correlation when trait divergence is reduced or eliminated.
Previous studies have shown that FAST and SLOW mice differ in response to MK-801. However, MK-801 often takes 20 to 30 min until its peak locomotor effects are observed , whereas ketamine is more similar to ethanol with respect to its rapid effects on locomotion (Filibeck and Castellano, 1980; Irfune et al., 1991) . Thus, we hypothesized that there would be a robust genetic correlation between sensitivity to ethanol-and ketamine-induced locomotion. In two initial experiments, we characterized the stimulant effects of ketamine in DBA/2J (D2) mice. We hypothesized that ketamine would induce locomotor stimulation in these mice, because they are an inbred strain that exhibits robust ethanol-induced locomotor stimulation (Crabbe et al., 1994) . These data also provided dose-response information that was used in subsequent studies in the selected lines of mice. We hypothesized that FAST mice would be more sensitive to ketamine's locomotor stimulant effects than SLOW mice, which we predicted would exhibit either no stimulation or locomotor depression in response to ketamine. We predicted that the reverse-selected lines would exhibit similar sensitivities to this drug. Finally, we also investigated ketamine's effects on the response to ethanol and predicted that ketamine would potentiate ethanol's effects due to the additive effects of ethanol and ketamine at the NMDA receptor.
METHODS

Subjects
Male D2 mice were purchased from The Jackson Laboratory (Bar Harbor, ME) and housed in the Portland Veterans Affairs animal facility for at least 13 days before study initiation. Mice from the two replicates of forward-selected lines (FAST-1, SLOW-1, FAST-2, and SLOW-2; generation S 37 G 63-67 ) and reverse-selected lines (r-FAST-1, r-SLOW-1, r-FAST-2, and r-SLOW-2; generation R 17 G [25] [26] [27] ) were bred and housed in the Veterans Affairs animal facility. Only female mice were available for these studies. At the time of testing, all mice were 50 to 99 days old and weighed 13 to 35 g. Behavioral testing occurred between 8:00 AM and 4:00 PM; the lights were on from 6:00 AM to 6:00 PM in the colony room in which the mice were housed. Room temperature was maintained between 20°C and 22°C. Mice were housed isosexually with mice of the same genotype in groups of two to five in clear, air-filtered polycarbonate (28 ϫ 18 ϫ 13 cm) cages with corncob bedding. Littermates were distributed across treatment groups. Water bottles and food (rodent laboratory blocks), suspended from wire lids, were available ad libitum except during activity testing.
Apparatus
Clear acrylic plastic boxes (40 ϫ 40 ϫ 30 cm) covered by plastic lids (44 ϫ 44 cm with 0.64-cm holes for ventilation) were placed in AccuScan (Columbus, OH) activity monitors. Consecutive interruptions of eight pairs of intersecting photocell beams, placed 2 cm above the floor, measured the distance traveled (cm) in 5-min periods. The monitors were set inside individual black acrylic chambers (Flair Plastics, Portland, OR), each containing foam insulation for exclusion of external noise, a fluorescent light mounted on the rear wall, and a ventilation fan, which also helped to mask extraneous laboratory sounds.
Drugs
All drugs were injected intraperitoneally by using 0.4-mm, 27-gauge hypodermic needles (Sherwood Medical, St. Louis, MO). Ethanol (Pharmco Products, Brookfield, CT; 20% v/v) was diluted from 100% in 0.9% saline and injected at a dose of 1 or 2 g/kg; these doses were chosen because they have been shown to stimulate locomotion in FAST mice (Palmer et al., 2002a) . Ketamine (Sigma, St. Louis, MO) was dissolved in 0.9% saline and injected in a 10 ml/kg volume at doses of 0, 5, 10, 20, 30, and 60 mg/kg. These doses were initially chosen from a study by Uchihashi et al. (1993) , which demonstrated that ketamine has stimulant effects in ddY mice within this dose range.
Procedure
On test days, mice were transferred, in their home cages, from the colony room to the activity testing room 45 to 60 min before testing began to allow acclimation to the test environment. After this period, each mouse was weighed, injected with saline, ethanol, and/or ketamine and placed immediately into the activity monitors. After the test session, mice were returned to their home cages. Each experiment was preceded by a habituation phase, which consisted of 2 days (experiments 3 and 4) or 3 days (experiments 1 and 2) in which mice were given only saline injections before being tested in the activity monitors. Drugs were administered on the following day. At the end of each experiment, mice were killed by carbon dioxide asphyxiation. All procedures complied with the Institutional Animal Care and Use Committee and National Institutes of Health guidelines.
Experiments 1 and 2
The general purpose of experiments 1 and 2 was to characterize the time course of ketamine's locomotor effects when administered alone and in combination with ethanol in a mouse strain known to be sensitive to ethanol's locomotor stimulant effects. Experiment 1 measured the response to ketamine alone in D2 mice. Mice received a saline or ketamine (5, 10, 20, 30, or 60 mg/kg) injection, followed immediately by a 30-min locomotor activity test. Data were collected in 5-min time periods. Each dose group contained 6 to 12 mice. Experiment 2 measured the effect of ketamine on ethanol-induced locomotion in D2 mice. This study was identical to experiment 1 except that all mice received a 2 g/kg ethanol injection immediately after the ketamine injection. Each dose group contained 12 mice.
Experiment 3
Experiment 3 measured the response to ketamine in FAST, SLOW, r-FAST, and r-SLOW selected lines of mice. Mice in these experiments received an injection of ketamine followed immediately by an injection of saline. The second injection was given to match the procedures used in the subsequent ketamine and ethanol study (experiment 4). After the second injection, mice were placed in the activity monitors for 20 min, and data were collected in 5-min time periods. The test duration was shortened by 10 min because, with the exception of rebound hyperexcitability seen at later time points after the highest dose, ketamine's locomotor stimulant effects occurred during the first 20 min of the test session. This shortened test duration allowed more efficient testing of the large number of mice in these experiments: 8 to 11 mice were tested per genotype ϫ treatment group, with the exception of FAST-2 and SLOW-2 mice treated with ketamine alone; 13 to 22 of these mice were tested per treatment group. The sample sizes were increased in this replicate in an attempt to detect apparently small, yet potentially significant, differences in these lines' responses to ketamine.
Experiment 4
Experiment 4 measured ketamine's effects on ethanol-induced locomotion in FAST and SLOW mice. Only forward-selected lines were tested; reverse-selected mice were not available for this experiment, because the lines have been terminated. The procedure was identical to experiment 3, except that mice received an injection of either 1 or 2 g/kg of ethanol immediately after the injection of ketamine. Initially, the 2 g/kg dose of ethanol was tested simultaneously with experiment 3; this dose was chosen because it was the dose used during the selective breeding of FAST and SLOW mice. However, on the basis of the initial result that ketamine decreased activity when mice were also given 2 g/kg of ethanol (see Fig. 4 ), we hypothesized that ketamine potentiated ethanol's effects on locomotion and that the observed reduction in locomotion in mice treated with ketamine was due to a potentiation of ethanol's incoordinating effects. To test this hypothesis, we subsequently administered ketamine in combination with 1 g/kg of ethanol, a dose of ethanol that produced a submaximal stimulant effect in FAST mice (Palmer et al., 2002a) . Using this dose, we could determine whether ketamine would potentiate ethanol-induced stimulation in FAST mice, as well as ethanol-induced sedation in SLOW mice, in a pattern consistent with a leftward shift of ethanol's doseresponse curve; 8 to 10 mice were tested per genotype ϫ treatment category.
Statistical Analyses
The dependent variable for all experiments was distance traveled in centimeters. For experiments 1 and 2, repeated-measures ANOVA was conducted with ketamine (0, 5, 10, 20, 30, or 60 mg/kg) as the betweengroups variable and 5-min interval as the repeated measure. For experiment 3, an initial four-way ANOVA was conducted, with direction of selection (forward or reverse), line (FAST or SLOW), replicate (1 or 2), and ketamine as the between-groups variables. Differences associated with replicate led to separate analyses of data from each set of replicate lines by using separate two-and three-way ANOVAs. Similarly, for experiment 4, an initial four-way ANOVA with line, replicate, ketamine, and ethanol (0, 1, or 2 g/kg) as between-groups variables was followed by individual analyses of data from the separate replicates. For all experiments, post hoc analyses were conducted by using simple main effects (SME) analyses and Newman-Keuls tests to investigate significant main effects and interactions. All statistical analyses were conducted with Statistica (StatSoft, Inc., Tulsa, OK).
RESULTS
Experiment 1
Ketamine had dose-dependent effects on locomotor activity in D2 mice [Fig. 1A; F(5, 61) 
Experiment 2
The distances traveled by mice treated with 2 g/kg ethanol alone in this experiment were approximately twice as great as those traveled by mice treated with saline alone in experiment 1. Ketamine dose-dependently inhibited this stimulant response [ Fig. 2A ; F(5,66) ϭ 11.7; p Ͻ 0.01]. Newman-Keuls post hoc tests on data accumulated across the 30-min test session indicated that ethanol-induced locomotion was significantly suppressed by the 20, 30, and 60 mg/kg ketamine doses (p Ͻ 0.01). Differential effects of the various ketamine doses across time were suggested by a significant ketamine ϫ time interaction [Fig. 2B; F(25, 330) ϭ 8.7; p Ͻ 0.01]. Stimulation to ethanol was reduced by the 5 and 10 mg/kg ketamine doses during the initial time periods, whereas the reduction induced by higher doses was more sustained.
Experiment 3
The peak stimulant response to ketamine, and the major differences between FAST and SLOW mice, occurred during the initial time periods of the 20-min test session. Therefore, data and analyses for the 10-min time period immediately after ketamine administration are presented in Figs. 3 and 4 . Responses of the forward-and reverseselected lines to ketamine were associated with ethanol sensitivity and ketamine dose, and were dependent on replicate [F(5,481) ϭ 4.0; p Ͻ 0.01 for the direction ϫ line ϫ replicate ϫ ketamine interaction]. Separate analyses of data from the two replicates indicated that ketamine doseresponse patterns were different in the forward-and In replicate 1, an effect of selection for differential ethanol sensitivity on ketamine sensitivity was indicated by a significant line ϫ ketamine interaction within the forwardselected lines [F(5,97) ϭ 6.3; p Ͻ 0.01]. No such interaction was found for the reverse-selected lines (p ϭ 0.86). SME analyses indicated that ketamine caused more stimulation in FAST-1 mice than in SLOW-1 mice at doses greater than 5 mg/kg (p Ͼ 0.01). In addition, the symmetrical alteration of ketamine sensitivity by reverse selection was indicated by significant direction of selection ϫ ketamine interactions within FAST and r-FAST mice [F(5,96) ϭ 2.9; p Ͻ 0.02] and within SLOW and r-SLOW mice [F(5,98) ϭ 4.6; p Ͻ 0.01]. The locomotor responses to ketamine were significantly blunted in r-FAST-1 mice relative to FAST-1 mice at doses greater than 10 mg/kg (p Ͼ 0.02) and were increased in r-SLOW-1 mice relative to SLOW-1 mice at doses greater than 5 mg/kg (p Ͼ 0.02).
In replicate 2, as mentioned previously, there was no significant interaction of direction of selection, line, and ketamine. However, a main goal of these studies was to determine whether selection for differential ethanol sensitivity also altered sensitivity to ketamine. Therefore, data from the forward-selected lines were analyzed separately. Selection-induced alterations in ketamine sensitivity were supported by a significant line ϫ ketamine interaction within the forward-selected lines [F(5,186) ϭ 3.1; p Ͻ 0.01]. SME analyses indicated that the response to ketamine was larger in FAST-2 compared with SLOW-2 mice at the 10 mg/kg dose but was lower at the 60 mg/kg dose (p Ͻ 0.05). When independently analyzed, there was no interaction of line and ketamine in the reverse-selected lines of replicate 2.
Experiment 4
The FAST and SLOW lines responded differently to the combinations of ethanol and ketamine, and these responses were dependent on replicate [F(10,678) Separate two-way ANOVAs of ketamine's and ethanol's effects were conducted within each mouse line. Ketamine and ethanol had combined effects in FAST-1, FAST-2, and SLOW-2 mice [F(10,144) ϭ 23.7, p Ͻ 0.01; F(10,189) ϭ 19.5, p Ͻ 0.01; and F(10,198) ϭ 3.9, p Ͻ 0.01, respectively, for the ketamine ϫ ethanol interactions]. There was a strong statistical trend for this interaction in SLOW-1 mice (p ϭ 0.06). SME analyses of these interactions indicated that the stimulant response to 1 g/kg ethanol was significantly potentiated by 10 mg/kg ketamine in FAST-1 mice but was attenuated by 60 mg/kg ketamine (p Ͻ 0.01). In FAST-2 mice, the stimulant response to 1 g/kg ethanol was potentiated by 10 and 20 mg/kg ketamine (p Ͻ 0.01). The responses to 2 g/kg ethanol were significantly attenuated by all doses of ketamine in FAST-1 mice and by doses higher than 5 mg/kg in FAST-2 mice. Together, these data suggest that ketamine treatment produces a leftward shift of ethanol's biphasic dose-response curve. In SLOW-2 mice, the sedative response to 1 g/kg ethanol was potentiated by 60 mg/kg ketamine (p Ͻ 0.01). The sedative response to 2 g/kg ethanol was not significantly altered by ketamine in this line of mice. Specific dose effects were not examined in the SLOW-1 line due to the nonsignificant ketamine ϫ ethanol interaction noted previously. 
DISCUSSION
These experiments provide strong evidence that some common genes influence sensitivity to the locomotor stimulant effects of ethanol and ketamine and that ethanol and ketamine have additive effects on locomotion. Differences in ketamine-induced locomotion were seen in both replicates of FAST and SLOW mice, suggesting the existence of a genetic correlation between this response and ethanolinduced locomotion. The observation that differences in ketamine sensitivity were abolished by reverse selection further strengthens the assertion that there are common genes that influence the locomotor response to these drugs. In addition, these results suggest that genes underlying the locomotor response to ketamine were not homozygously fixed, even after selective breeding for 37 generations. If no heterogeneity had been present at these loci, then reverse selection would have had no effect on this response. This same argument applies to ethanol-induced locomotion, because reverse selection would not have been possible without some residual heterogeneity at relevant loci. It is unknown why these genes would not be fixed after 37 generations of selection; Phillips et al. (2002) have suggested that this may be due to epistatic phenomena (gene ϫ gene interaction) or that selection may have favored heterozygosity at some relevant loci.
Ketamine's Effects on Locomotion
There were significant differences between FAST and SLOW mice of both replicates in response to ketamine. However, the difference between the replicate 2 lines was considerably smaller than that of the replicate 1 lines. Although FAST-2 mice were significantly more stimulated than SLOW-2 mice at 10 mg/kg, the actual levels of stimulation were higher than those of SLOW-2 mice at other doses that were a part of the stimulant limb of ketamine's dose-response curve. The lower response of FAST-2 mice to 60 mg/kg ketamine suggests that they may be less sensitive to the stimulant effects of this dose of ketamine or that they may be more sensitive to this dose's ataxic or sedative effects compared with SLOW-2 mice. This suggests that FAST-2 mice are more sensitive to ketamine than SLOW-2 mice despite the apparently small magnitude of the differences between these lines. In addition, although the lines are created in replicate, they are not likely to be genetically identical. Because the locomotor response to ethanol is polygenically influenced (Demarest et al., 2001; , differing combinations of genetic differences could lead to increases and decreases in ethanol sensitivity. In addition to the NMDA receptor, there are other neural substrates likely to be important in determining sensitivity to ethanol's locomotor stimulant effects in the FAST and SLOW lines. Both replicates of FAST and SLOW mice differ in their locomotor responses to several GABAergic drugs, including pentobarbital, diazepam, and allopregnanolone (Palmer et al., 2002a,b; Phillips et al., 1992) , and these differences were attenuated or eliminated in the reverse-selected lines (Palmer et al., 2002b) . These data suggest that ethanol's actions at GABA receptors are also important for its locomotor effects. In addition, ethanol's known interactions with monoaminergic and neuroendocrine systems are likely to be important as mediators of its reinforcing and stimulant effects (Di Chiara and Imperato, 1988; Liljequist et al., 1981; Phillips and Shen, 1996) .
Other studies support divergent responses to NMDA antagonists between lines of mice selected for differential ethanol sensitivity. As mentioned in the introduction, reported that both replicates of FAST and SLOW mice differed in locomotor responses to high doses of MK-801, another NMDA antagonist with strong stimulant properties. Direct support for functional differences in NMDA receptors between FAST and SLOW mice was found in experiments in which microsacs prepared from the brains of SLOW mice were more sensitive to ethanol's inhibition of glutamate-stimulated calcium influx through NMDA receptors than those of FAST mice (Daniell and Phillips, 1994) . Another selective breeding project produced mice with high (long sleep, or LS) and low (short sleep, or SS) sensitivity to ethanol's hypnotic (loss of righting reflex) effects; these mice also differ in their sensitivity to ethanol's locomotor stimulant effects (Sanders, 1976) . FAST and SS mice have in common greater levels of ethanol-induced locomotion and decreased sensitivity to ethanol's hypnotic effects, compared with their SLOW and LS counterparts (Church et al., 1979; Erwin and Jones, 1993; Phillips et al., 2002) . Hanania and Zahniser (2002) found that inbred SS and LS mice also differ in their response to MK-801, phencyclidine, and ketamine. Further, Velardo et al. (1998) found higher NMDA receptor densities in discrete brain areas of SS mice than in LS mice. These results suggest that differences in NMDA receptor function or density may be partially responsible for the differences observed in these selected lines of mice.
We also characterized the detailed time course of the responses to ketamine in D2 mice. This strain of mice is sensitive to ethanol's stimulant effects compared with some other strains, including C57BL/6 (B6), a strain often compared to D2 (Crabbe et al., 1994) . D2 and FAST mice were similar in this study in that they displayed robust ketamineinduced stimulation compared with SLOW mice, suggesting that their sensitivity to ketamine's stimulant effects paralleled their sensitivity to ethanol's stimulant effects. Therefore, it would be interesting to test the effects of ketamine on locomotor activity in B6 mice to determine whether this strain's insensitivity to ethanol's stimulant effects parallels its response to ketamine. Other studies have reported that ketamine has locomotor stimulant effects in B6 mice (Liljequist, 1991) , and Filibeck and Castellano (1980) have reported that this effect is larger than that in D2 mice. However, the latter study reported locomotor depression in D2 mice, which is inconsistent with our findings. The source of this inconsistency is not known and may be related to procedural differences or the use of a different testing apparatus.
Ketamine's Effects on Ethanol-Induced Locomotion
When given in combination, ketamine and ethanol produced additive effects on locomotion in FAST mice. This suggests that ketamine produced a leftward shift in ethanol's dose-response curve, possibly through an additive effect of ketamine and ethanol at the NMDA receptor. Consistent with the additive effects of these two drugs, when a relatively low dose of ethanol was tested, ketamine enhanced ethanol-induced stimulation in FAST mice. These results are similar to those from previous studies showing potentiation of ethanol's effects by low doses of MK-801 (Kuribara, 1994; Meyer and Phillips, 2003; . In SLOW-1 mice, a high dose of ketamine potentiated the locomotor depressant response to 1 g/kg ethanol, although this effect was not statistically significant in SLOW-2 mice (p ϭ 0.06). Because these mice were bred for increased sensitivity to ethanol's locomotor depressant effect, a likely explanation is that further decreases in locomotion could not be measured due to a floor effect. Potentiation of ethanol's stimulant effect was not seen when ketamine was administered with the higher 2 g/kg dose of ethanol, possibly due to increases in ataxia and sedation produced by the drug combination, although we did not design these studies to measure ataxia or sedation.
It is interesting to note that although FAST-1 and -2 mice differed in their sensitivity to ketamine alone, the effects of ketamine on ethanol-induced locomotion were very similar between these lines. However, there are some results that suggest that FAST-2 mice are slightly less sensitive to ketamine's potentiation of ethanol's effects. For example, 5 mg/kg ketamine decreased the response to 2 g/kg ethanol in FAST-1 mice but not FAST-2 mice. Further, in FAST-1 mice, 10 mg/kg ketamine potentiated the response to 1 g/kg ethanol, whereas both 10 and 20 mg/kg potentiated this response in FAST-2 mice. Therefore, the 20 mg/kg ketamine dose may have potentiated the sedative/ ataxic effects of 1 g/kg ethanol to a greater degree in FAST-1 than in FAST-2 mice.
Glutamatergic interactions within the mesolimbic dopamine system may play a role in ethanol-induced locomotion. Ethanol has NMDA antagonist properties itself, and when it is administered in combination with an NMDA antagonist such as MK-801, its locomotor and ataxic effects are potentiated (Kuribara, 1994; Meyer and Phillips, 2003; . However, noncompetitive NMDA antagonists may elicit locomotion by actually enhancing glutamatergic transmission within the mesolimbic dopamine system. For example, Mathé et al. (1998) showed that non-NMDA glutamate receptor antagonists administered directly into the ventral tegmental area blocked dopamine release in the nucleus accumbens, as well as increases in locomotion elicited by a systemic injection of MK-801. These data suggest that MK-801 may be enhancing glutamatergic tone by inducing glutamate release, thereby resulting in the stimulation of cells in the ventral tegmental area via non-NMDA glutamate receptors. The same may be true for ethanol. Yan et al. (1998) showed that 2 g/kg ethanol caused a decrease in glutamate levels within the nucleus accumbens of Sprague-Dawley rats. However, this is a relatively high ethanol dose in rats, and this strain of rats typically shows locomotor depression rather than activation in response to ethanol (Frye and Breese, 1981; Lamble and Rydberg, 1982) . Studies with high-alcoholsensitive and low-alcohol-sensitive rats, selectively bred for differential initial sensitivity to ethanol's hypnotic (loss of righting reflex) effects, have shown that the locomotor response to ethanol in these lines also differs. Whereas high-alcohol-sensitive rats exhibited locomotor depression to 2 g/kg ethanol, the low-alcohol-sensitive rats displayed no locomotor response (Schechter and Krimmer, 1992) . Dahchour et al. (2000) found ethanol-induced decreases in glutamate release within the nucleus accumbens in highalcohol-sensitive rats, whereas low-alcohol-sensitive rats showed an increase in release. This suggests that sensitivity to ethanol-induced locomotor activity, loss of righting reflex, and glutamate release in the nucleus accumbens are genetically related and may be related to ethanol's NMDAantagonist properties.
In conclusion, these studies indicate that there is an overlap in the genes that influence the locomotor responses to ketamine and ethanol. Further, ketamine and ethanol had additive effects on locomotion, which suggests that these drugs act through a common mechanism, possibly the NMDA receptor, to produce changes in locomotor activity.
